Sei Investments Co. Boosts Stock Position in Clorox Co (NYSE:CLX)

Sei Investments Co. boosted its holdings in Clorox Co (NYSE:CLX) by 0.7% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 60,070 shares of the company’s stock after purchasing an additional 439 shares during the quarter. Sei Investments Co.’s holdings in Clorox were worth $13,212,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Geode Capital Management LLC grew its stake in shares of Clorox by 5.5% during the 1st quarter. Geode Capital Management LLC now owns 2,415,807 shares of the company’s stock worth $417,876,000 after purchasing an additional 125,821 shares during the period. Bank of New York Mellon Corp lifted its holdings in Clorox by 0.3% during the second quarter. Bank of New York Mellon Corp now owns 1,505,670 shares of the company’s stock worth $330,299,000 after buying an additional 3,959 shares during the period. APG Asset Management N.V. boosted its position in Clorox by 8,909.5% during the 1st quarter. APG Asset Management N.V. now owns 1,108,615 shares of the company’s stock valued at $158,426,000 after acquiring an additional 1,096,310 shares in the last quarter. Legal & General Group Plc increased its holdings in shares of Clorox by 4.2% in the 1st quarter. Legal & General Group Plc now owns 1,082,973 shares of the company’s stock valued at $187,522,000 after acquiring an additional 43,604 shares during the period. Finally, California Public Employees Retirement System raised its position in shares of Clorox by 1.1% in the 1st quarter. California Public Employees Retirement System now owns 1,058,987 shares of the company’s stock worth $183,469,000 after acquiring an additional 11,503 shares in the last quarter. 79.18% of the stock is owned by hedge funds and other institutional investors.

In related news, SVP Andrew J. Mowery sold 12,932 shares of the firm’s stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $235.97, for a total transaction of $3,051,564.04. Following the completion of the transaction, the senior vice president now directly owns 18,456 shares of the company’s stock, valued at $4,355,062.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Diego J. Barral sold 10,041 shares of the business’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $235.59, for a total transaction of $2,365,559.19. Following the completion of the sale, the senior vice president now owns 13,931 shares in the company, valued at approximately $3,282,004.29. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

A number of equities analysts have commented on CLX shares. Credit Suisse Group boosted their target price on shares of Clorox from $185.00 to $200.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. JPMorgan Chase & Co. increased their target price on shares of Clorox from $203.00 to $235.00 and gave the company an “overweight” rating in a research report on Thursday, July 16th. Deutsche Bank lifted their price target on shares of Clorox from $174.00 to $223.00 and gave the stock a “hold” rating in a report on Monday, July 27th. Zacks Investment Research lowered shares of Clorox from a “buy” rating to a “hold” rating and set a $249.00 price target on the stock. in a report on Thursday, August 6th. Finally, Citigroup lifted their price target on shares of Clorox from $206.00 to $246.00 and gave the stock a “neutral” rating in a report on Tuesday, August 4th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $202.93.

Clorox stock opened at $210.35 on Wednesday. The firm has a market capitalization of $26.45 billion, a price-to-earnings ratio of 28.52, a P/E/G ratio of 3.99 and a beta of 0.23. Clorox Co has a 12-month low of $144.12 and a 12-month high of $239.87. The firm has a 50 day moving average of $224.59 and a 200 day moving average of $204.63. The company has a current ratio of 1.42, a quick ratio of 1.10 and a debt-to-equity ratio of 3.06.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, August 3rd. The company reported $2.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.00 by $0.41. The business had revenue of $1.98 billion during the quarter, compared to analyst estimates of $1.86 billion. Clorox had a net margin of 13.97% and a return on equity of 138.70%. The company’s revenue was up 21.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.88 earnings per share. On average, analysts predict that Clorox Co will post 7.76 EPS for the current year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: What causes a recession?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.